Roland Asmar

3.1k total citations · 1 hit paper
39 papers, 2.5k citations indexed

About

Roland Asmar is a scholar working on Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism and Surgery. According to data from OpenAlex, Roland Asmar has authored 39 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Cardiology and Cardiovascular Medicine, 9 papers in Endocrinology, Diabetes and Metabolism and 8 papers in Surgery. Recurrent topics in Roland Asmar's work include Blood Pressure and Hypertension Studies (27 papers), Cardiovascular Health and Disease Prevention (13 papers) and Hormonal Regulation and Hypertension (8 papers). Roland Asmar is often cited by papers focused on Blood Pressure and Hypertension Studies (27 papers), Cardiovascular Health and Disease Prevention (13 papers) and Hormonal Regulation and Hypertension (8 papers). Roland Asmar collaborates with scholars based in France, United States and Italy. Roland Asmar's co-authors include Athanase Bénétos, Bruno Pannier, Jirar Topouchian, Pierre Laurent, Anne‐Marie Brisac, Bernard Lévy, Michel E. Safar, Chris Adamopoulos, Jeanne-Marie Bureau and Frédérique Thomas and has published in prestigious journals such as Circulation, Kidney International and Hypertension.

In The Last Decade

Roland Asmar

39 papers receiving 2.4k citations

Hit Papers

Assessment of Arterial Di... 1995 2026 2005 2015 1995 250 500 750 1000

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Roland Asmar France 19 2.1k 456 381 282 216 39 2.5k
Tine De Backer Belgium 20 2.1k 1.0× 477 1.0× 529 1.4× 225 0.8× 187 0.9× 102 2.9k
Susanne Rasmussen Denmark 20 2.1k 1.0× 441 1.0× 365 1.0× 440 1.6× 167 0.8× 32 2.7k
Isaac Kobrin United States 28 2.3k 1.1× 627 1.4× 277 0.7× 319 1.1× 157 0.7× 100 2.9k
Bruno Pannier France 16 3.0k 1.4× 568 1.2× 421 1.1× 380 1.3× 241 1.1× 29 3.4k
Jan Filipovský Czechia 23 2.5k 1.2× 476 1.0× 455 1.2× 398 1.4× 162 0.8× 105 3.3k
Jonathan Sackner‐Bernstein United States 17 2.6k 1.2× 444 1.0× 290 0.8× 183 0.6× 300 1.4× 45 3.2k
D. Duprez Belgium 10 1.2k 0.6× 362 0.8× 294 0.8× 292 1.0× 133 0.6× 25 1.5k
M. E. Safar France 23 1.6k 0.7× 328 0.7× 358 0.9× 189 0.7× 80 0.4× 65 2.0k
Salvatore Paterna Italy 24 1.6k 0.8× 625 1.4× 330 0.9× 185 0.7× 68 0.3× 107 2.3k
A. Mosterd Netherlands 7 2.3k 1.1× 250 0.5× 313 0.8× 170 0.6× 169 0.8× 9 2.8k

Countries citing papers authored by Roland Asmar

Since Specialization
Citations

This map shows the geographic impact of Roland Asmar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roland Asmar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roland Asmar more than expected).

Fields of papers citing papers by Roland Asmar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roland Asmar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roland Asmar. The network helps show where Roland Asmar may publish in the future.

Co-authorship network of co-authors of Roland Asmar

This figure shows the co-authorship network connecting the top 25 collaborators of Roland Asmar. A scholar is included among the top collaborators of Roland Asmar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roland Asmar. Roland Asmar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mancia, Giuseppe, Roland Asmar, Celso Amodeo, et al.. (2014). Comparison of single-pill strategies first line in hypertension. Journal of Hypertension. 33(2). 401–411. 30 indexed citations
3.
Parati, Gianfranco, et al.. (2010). Effectiveness and safety of high-dose valsartan monotherapy in hypertension treatment: the ValTop study. Hypertension Research. 33(10). 986–994. 8 indexed citations
4.
Asmar, Roland & Hassan Hosseini. (2009). Endpoints in clinical trials: does evidence only originate from ‘hard’ or mortality endpoints?. Journal of Hypertension. 27(Suppl 2). S45–S50. 9 indexed citations
5.
Færgeman, Ole, et al.. (2008). Efficacy and Tolerability of Rosuvastatin and Atorvastatin when Force-Titrated in Patients with Primary Hypercholesterolemia. Cardiology. 111(4). 219–228. 27 indexed citations
6.
Asmar, Roland. (2006). Targeting effective blood pressure control with angiotensin receptor blockers. International Journal of Clinical Practice. 60(3). 315–320. 23 indexed citations
7.
Mattace‐Raso, Francesco, Tischa J. M. van der Cammen, Fakhredin A. Sayed‐Tabatabaei, et al.. (2004). Angiotensin-converting enzyme gene polymorphism and common carotid stiffness. Atherosclerosis. 174(1). 121–126. 43 indexed citations
8.
Queneau, Patrice, Roland Asmar, & M Safar. (2002). [Placebo effect on diastolic, systolic and pulsed arterial pressure].. PubMed. 31(26). 1220–3. 2 indexed citations
9.
Asmar, Roland. (2001). Pulse pressure and aortic pulse wave are markers of cardiovascular risk in hypertensive populations. American Journal of Hypertension. 14(2). 91–97. 146 indexed citations
10.
Asmar, Roland, et al.. (2001). Assessment of outcomes other than systolic and diastolic blood pressure: pulse pressure, arterial stiffness and heart rate. Blood Pressure Monitoring. 6(6). 329–333. 18 indexed citations
11.
Asmar, Roland. (2001). Evaluation of the placebo effect and reproducibility of blood pressure measurement in hypertension. American Journal of Hypertension. 14(6). 546–552. 60 indexed citations
12.
Safar, Michel E., A. Rudnichi, & Roland Asmar. (2000). Drug treatment of hypertension. Journal of Hypertension. 18(9). 1159–1163. 29 indexed citations
13.
Mallion, Jean-Michel, et al.. (1998). Twenty-Four Hour Antihypertensive Efficacy of Indapamide, 1.5-Mg Sustained Release: Results of Two Randomized Double-Blind Controlled Studies. Journal of Cardiovascular Pharmacology. 32(4). 673–678. 23 indexed citations
14.
Asmar, Roland, et al.. (1996). [Evaluation of trough/peak ratio of indapamide 1.5 mg sustained-release form assessed by ambulatory blood pressure monitoring].. PubMed. 89 Spec No 4. 27–38. 5 indexed citations
15.
Asmar, Roland. (1996). Repeated measurements of non invasive ambulatory blood pressure: distinction between reproducibility and the proper effect of placebo.. American Journal of Hypertension. 9(4). 110A–110A. 14 indexed citations
16.
Bénétos, Athanase, et al.. (1996). Arterial stiffness, hydrochlorothiazide and converting enzyme inhibition in essential hypertension.. PubMed. 10(2). 77–82. 34 indexed citations
17.
Mallion, Jean-Michel, Jean‐François Renucci, B. Vaı̈sse, et al.. (1993). [Non-invasive ambulatory measurement of arterial pressure. Recommendations of the measurement group of the French Society of Arterial Hypertension].. PubMed. 86(8). 1137–42. 7 indexed citations
18.
Djian, Jacques, et al.. (1990). Effects of Sustained-Release Diltiazem on Blood Pressure and Serum Lipids. Journal of Cardiovascular Pharmacology. 16. S38–S45. 2 indexed citations
19.
Asmar, Roland, et al.. (1989). Angiotensin converting enzyme inhibition, pulse wave velocity and ambulatory blood pressure measurements in essential hypertension.. PubMed. 11 Suppl 2. 535–44. 2 indexed citations
20.
Safar, M. E., et al.. (1987). Increased pulse pressure in patients with arteriosclerosis obliterans of the lower limbs.. Arteriosclerosis An Official Journal of the American Heart Association Inc. 7(3). 232–237. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026